Clinical Usefulness of Cell-based Indirect Immunofluorescence Assay for the Detection of Aquaporin-4 Antibodies in Neuromyelitis Optica Spectrum Disorder

Clinical Usefulness of Cell-based Indirect Immunofluorescence Assay for the Detection of Aquaporin-4 Antibodies in Neuromyelitis Optica Spectrum Disorder

Bibliographic Details
Main Authors:	Kang, Eun-suk, Min, Ju-Hong, Lee, Kwang Ho, Kim, Byoung Joon
Format:	Online
Language:	English
Published:	The Korean Society for Laboratory Medicine 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3427820/

Similar Items

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
by: Waters, Patrick, et al.
Published: (2016)

Antibody to Aquaporin 4 in the Diagnosis of Neuromyelitis Optica
by: Paul, Friedemann, et al.
Published: (2007)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
by: Schanda, Kathrin, et al.
Published: (2015)

Anti-Aquaporin-1 Autoantibodies in Patients with Neuromyelitis Optica Spectrum Disorders
by: Tzartos, John S., et al.
Published: (2013)

Fatal anti-aquaporin-4 seropositive neuromyelitis optica spectrum disorder in tuberculosis
by: Sridhar, Siddharth, et al.
Published: (2014)

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
by: Ramanathan, Ramnath Santosh, et al.
Published: (2014)

Neuromyelitis optica spectrum disorders: An update
by: Pandit, Lekha
Published: (2015)

Evaluation of a Multiparametric Immunofluorescence Assay for Standardization of Neuromyelitis Optica Serology
by: Granieri, Letizia, et al.
Published: (2012)

Cerebral Cortex Involvement in Neuromyelitis Optica Spectrum Disorder
by: Kim, Woojun, et al.
Published: (2016)

Clinical Efficacy of Plasmapheresis in Patients with Neuromyelitis Optica Spectrum Disorder and Effects on Circulating Anti-Aquaporin-4 Antibody Levels
by: Kim, Su-Hyun, et al.
Published: (2013)

Persistent Hyperthermia in a Patient with Aquaporin-4-Antibody-Positive Neuromyelitis Optica Spectrum Disorder
by: Hsu, Chia-Lun, et al.
Published: (2016)

Cerebrospinal Fluid Aquaporin-4 Antibody Levels in Neuromyelitis Optica Attacks
by: Sato, Douglas Kazutoshi, et al.
Published: (2014)

Brain Abnormalities in Neuromyelitis Optica Spectrum Disorder
by: Kim, Woojun, et al.
Published: (2012)

Acute and Chronic Management of Neuromyelitis Optica Spectrum Disorder
by: Sherman, Elena, et al.
Published: (2015)

Profile of neuromyelitis optica and spectrum disorders in an Indian cohort
by: Koudriavtseva, Tatiana, et al.
Published: (2015)

Sleep abnormality in neuromyelitis optica spectrum disorder
by: Song, Yijun, et al.
Published: (2015)

Neuromyelitis Optica Spectrum Disorder Associated with Cervical Spondylosis
by: Zhou, Yuan, et al.
Published: (2015)

Neuromyelitis optica spectrum disorders without and with autoimmune diseases
by: Zhang, Bingjun, et al.
Published: (2014)

Three cases of neuromyelitis optica spectrum disorder
by: Matsusue, Eiji, et al.
Published: (2016)

Circulating Memory T Follicular Helper Cells in Patients with Neuromyelitis Optica/Neuromyelitis Optica Spectrum Disorders
by: Fan, Xueli, et al.
Published: (2016)

Neuromyelitis optica and neuromyelitis optica spectrum disorder: Natural history and long-term outcome, an Indian experience
by: Jagtap, Sujit Abajirao, et al.
Published: (2015)

Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disorders
by: Tuller, Friederike, et al.
Published: (2016)

Evaluation of Clinical Interest of Anti-Aquaporin-4 Autoantibody Followup in Neuromyelitis Optica
by: Chanson, Jean-Baptiste, et al.
Published: (2013)

Detection of anti-aquaporin-4 autoantibodies in the sera of Chinese neuromyelitis optica patients★
by: Li, Miao, et al.
Published: (2013)

Neuromyelitis Optica
by: Misra, M. C., et al.
Published: (1953)

Low Levels of Vitamin D in Neuromyelitis Optica Spectrum Disorder: Association with Disease Disability
by: Min, Ju-Hong, et al.
Published: (2014)

The Frequency of Anti-Aquaporin-4 Ig G Antibody in Neuromyelitis Optica and Its Spectrum Disorders at a Single Tertiary Referral Center in Malaysia
by: Viswanathan, Shanthi, et al.
Published: (2014)

Comparative epidemiology and quantitative neuroimaging of neuromyelitis optica spectrum disorder and multiple sclerosis
by: Chou, I-Jun
Published: (2017)

Relapse of Neuromyelitis Optica Spectrum Disorder Associated with Intravenous Lidocaine
by: Uzawa, Akiyuki, et al.
Published: (2011)

A clinical and radiological profile of neuromyelitis optica and spectrum disorders in an Indian cohort
by: Barhate, Kavita Sohan, et al.
Published: (2014)

Cerebrospinal fluid mitochondrial DNA in neuromyelitis optica spectrum disorder
by: Kazuya Yamashita, et al.
Published: (2018-04-01)

Use of rituximab and risk of re-hospitalization for children with neuromyelitis optica spectrum disorder
by: Sabrina Gmuca, et al.
Published: (2018-04-01)

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
by: Wingerchuk, Dean M., et al.
Published: (2015)

Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder
by: Chavarro, Velina S., et al.
Published: (2016)

Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus
by: Sepúlveda, Maria, et al.
Published: (2016)

Serological markers associated with neuromyelitis optica spectrum disorders in South India
by: Pandit, Lekha, et al.
Published: (2016)

Neuromyelitis optica spectrum disorder in a patient with Kikuchi-Fujimoto disease
by: Kaku, Michelle, et al.
Published: (2016)

Early indicators of relapses vs pseudorelapses in neuromyelitis optica spectrum disorder
by: Kessler, Remi A., et al.
Published: (2016)

Clinical Features of Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
by: Chen, Hai, et al.
Published: (2016)

Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75
by: Krumbholz, Markus, et al.
Published: (2015)